DSM to double ARA output

Related tags Martek Ara Docosahexaenoic acid Fatty acid

DSM Food Specialties is to double the volume of arachidonic acid
(ARA) produced for its US partner Martek Biosciences to meet
rapidly growing demand, the Dutch firm said this week, writes
Dominique Patton.

The companies will also increase their R&D collaboration to look for new applications for the ingredient, such as in animal feed.

ARA is a long-chain fatty acid which, in combination with docosahexaenoic acid (DHA), supports infant brain development. Martek produces DHA at its own facilities by fermenting microalgae. But it needs to co-operate with the Netherlands-based DSM on production of ARA, sharing intellectual property on the manufacturing process, to offer both fatty acids to its key clients.

The recent launches of infant formula containing a combination of the two fatty acids by all of the leading formula makers has triggered a major surge in demand.

US market share for infant formula containing Martek's oils grew from less than 10 per cent in 2002 to greater than 40 per cent by the end of last year. Almost 90 per cent of Martek's fourth quarter revenues was generated by sales of DHA and ARA to Mead Johnson, Wyeth, Abbott Laboratories and Nestle, with supplemented term formulas now marketed by these four companies in over 30 countries around the world, according to Martek.

Supply problems were further impacted by a national power cut in Italy last year, affecting production at DSM's plant in Capua. This raised costs for the US firm and also resulted in DHA inventories piling up as they could not be blended with ARA. A new DSM plant, scheduled to open in the US this year, is expected to reduce the impact of factors that could affect the production at any one plant.

Under the new agreement, Martek also gains access to certain of DSM's patents and intellectual property and will have certain ARA production rights. DSM, as Martek's supplier of ARA, will have access to Martek's technology related to the manufacture of ARA, and is granted rights to use Martek's technology in non-human fields, including animal feeds.

"This agreement should add significant long-term ARA production capacity, improve production efficiency and allow the companies to explore new ARA uses,"​ said Henry Linsert, Martek's chairman and CEO.

DSM has been Martek's supplier of ARA since 1997.

Related topics Omega-3s & Nutritional oils

Related news

Show more

Related products

Nutritional Solutions for Women's Health

Nutritional Solutions for Women's Health

Content provided by INNOBIO Corporation Limited | 04-Oct-2023 | White Paper

INNOBIO provides innovative solutions for women to overcome a variety of health challenges throughout the life cycle, from emotional health, PMS management,...

Golden Omega® Sustainability Strategy

Golden Omega® Sustainability Strategy

Content provided by LEHVOSS Nutrition | 11-Sep-2023 | Data Sheet

Commitment to sustainability at Golden Omega® is ever growing as they continue to put objectives in place to secure a better environment for the future....

Omega-3:Nutrition and Application Insight

Omega-3:Nutrition and Application Insight

Content provided by Cabio Biotech (Wuhan) Co., Ltd | 31-Jul-2023 | White Paper

Omega-3 long-chain polyunsaturated fatty acids (PUFAs) have numerous positive health benefits and are among the most extensively studied micronutrients....

Related suppliers

Follow us

Products

View more

Webinars